Contact Us / Sitemap / Directions / Patients and Visitors / Career Opportunities / 1-866-WINTHROP
pay your hospital bill pay your doctor's bill
Winthrop University Hospital

Patients diagnosed with Acute Hereditary Angioedema

Summary

The purpose of this study is to evaluate immunogenicity (ability to trigger an immune response) and hypersensitivity (undesirable reaction produced by the immune system) upon exposure to an FDA approved medication for patients who suffer from sudden HAE attacks.

Description

Winthrop University Hospital Clinical Trials Center is Seeking participants that are at least 16 years of age and have been diagnosed with Acute Hereditary Angioedema. Hereditary Angioedema (HAE) is a very rare and potentially life-threatening genetic condition that occurs in about 1 in 10,000 to 1 in 50,000 people. HAE symptoms include episodes of swelling in various body parts including the hands, feet, face and airway. Patients may also have bouts of excruciating abdominal pain, nausea and vomiting that is caused by swelling in the intestinal wall. Airway swelling is particularly dangerous and can lead to death by asphyxiation

Inclusion/exclusion

To be eligible for this clinical research study, you must; ??Be 16 years old or older ??Have been diagnosed with Acute Hereditary Angioedema

Principal Investigator

Mark Davis-Lorton, MD

Department

Allergy & Immunology

Email

clintrials@winthrop.org

Other Contact

For more information please call: 516-663-9582
Contact Us / Sitemap / Directions / Career Opportunities / Financial Assistance / Policies
1-866-WINTHROP
subscribe
Winthrop-University Hospital
259 First Street | Mineola NY 11501 | 516-663-0333


This site provides information as a resource. It is not a substitute for professional medical advice.
Always consult a physician or healthcare provider for treatment and guidance toward good health.
Copyright © 2014 Winthrop-University Hospital. All rights reserved.
Web site by: Long Island Web Design
page-bottom